Nalaganje...
Immune Checkpoint Inhibitors in NSCLC
Lung cancer is the leading cause of cancer-related mortality worldwide. Cytotoxic chemotherapy and tyrosine kinase inhibitors provide palliation and prolong survival, however, the median survival for patients with metastatic disease remains poor and more effective therapies are needed. Immune checkp...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4216599/ https://ncbi.nlm.nih.gov/pubmed/25096781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-014-0305-5 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|